DEWB AG Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
Ansprechpartner: Marco Scheidler
Tel.: +49 3641 31000-30


10.12.2014 - 10:09 | DEWB AG Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
10.12.2014 - 10:05 | DEWB AG Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
05.12.2014 - 10:38 | DEWB AG Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
05.12.2014 - 10:37 | DEWB AG Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
23.09.2014 - 10:05 | DEWB AG Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
Business news for the stock market

DEWB AG Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG: DEWB Investment Holding LemnaTec Secures Equity Financing from Anterra Capital

Aachen, Germany (pta018/03.03.2015/11:51) - March 3, 2015 - LemnaTec GmbH ("LemnaTec"), a leader in high-throughput research platforms and analysis software for plants, today announced that it has agreed a Eur5 million equity investment from Anterra Capital. The proceeds from the financing will be used to accelerate LemnaTec's continued growth and market expansion globally. This investment follows a previous financing round led by German private equity firm DEWB and underlines LemnaTec's position as one of the largest providers of systems and software for image capture and data processing of plants and other research organisms.

"The partnership between Anterra and LemnaTec will help accelerate our expansion, particularly in the USA, and allow us to extend our software and service capabilities," said Dirk Vandenhirtz, CEO and founder of LemnaTec. "We are now backed by two strong institutional investors and I am very confident that Anterra will energetically support our continued growth with their technology expertise and extensive industry contacts."

Dudley Hawes, a Partner at Anterra Capital, said, "Our investment in LemnaTec provides a platform for the company to grow and support its already global customer base. We see tremendous potential in LemnaTec's data and bioinformatics tools and believe that the company will contribute massively to the infrastructure needed to better connect and use genotyping and phenotyping information. We look forward to working with the team to strengthen operations and realise LemnaTec's significant potential."

LemnaTec sells hardware and software for taking digital images of plants and for processing those images to produce phenotypic data. LemnaTec's products are designed to improve the performance of phenotyping results in R&D and this is done using a range of products - low throughput systems for lab monitoring, high throughput systems for monitoring thousands of plants in a greenhouse or systems suitable for research in open fields. A typical greenhouse installation would include camera and sensor systems, application and analysis software, high-speed data processing components, as well as some form of automation engineering for plant handling and growth management. LemnaTec has also developed a suite of software tools for plant phenotyping covering image acquisition, image processing and data mining to help attaining a desired phenotype for any given condition.

Announcement of this financing follows several notable achievements by LemnaTec in recent months including opening an office in St. Louis, USA and starting construction of a high output field based phenotyping facility in the UK with Rothamsted Research.

About LemnaTec GmbH
LemnaTec was founded in 1998 and since then the company has developed a range of research platforms and analysis software for agricultural chemistry, plant cultivation, biotechnology and pharmaceutical research. LemnaTec employs a multi-disciplinary team of biologists, physicians, chemists, bioinformaticians and ecotoxicologists, as well as hardware and software engineers, and together this team services a large estate of internationally renowned companies and institutes. For further information please visit

About Anterra Capital
Anterra Capital, a growth capital fund, is jointly funded by Moonray Investors, the proprietary investment arm of FIL Limited, the parent company of Fidelity Worldwide Investment, and Rabo Private Equity, the proprietary private equity arm of Rabobank. Anterra Capital invests in fast growing companies that are working to make the global food supply chain safer, more efficient and more sustainable. For further information please visit

About DEWB
Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG (DEWB AG, Entry Standard, WKN: 804100 / ISIN: DE0008041005) is an investment company specialising on young and established medium-sized companies. Their investment activities are focused on high-growth companies with the technology focus on photonics and sensor technology, as well as their fields of application in production and automation engineering and adjacent areas. They support these companies with equity capital, corporate development expertise, and a broad industry network. Since 1997, they have invested more than 360 million Euro in 59 companies and generated more than 465 million Euro in returns from 43 exits, including eight initial public offerings. The company is headquartered in Jena, Germany, one of the country's most successful regions for technology and science, with a long-standing tradition in the field of optical technologies and one of the most important European centers for photonics. For further information please visit

emitter: DEWB AG Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
Fraunhoferstraße 1
07743 Jena
contact person: Marco Scheidler
phone: +49 3641 31000-30
stock exchanges: basic board in Frankfurt, free market in Munich, free market in Stuttgart; open market in Berlin
ISIN(s): DE0008041005 (share)
98.731 Abonnenten
201.806 Meldungen
83.493 Pressefotos


09.08.2022 - 15:30 | Financial Planning Standards Board Deutschland e.V.
09.08.2022 - 12:38 | pressetext.redaktion
09.08.2022 - 12:20 | SRH AlsterResearch AG
09.08.2022 - 12:10 | SRH AlsterResearch AG
09.08.2022 - 12:00 | SRH AlsterResearch AG